Desire support
Can be reviewed for patients seeking support around low sexual desire or reduced interest.
Back to peptide library
Sexual Health
PT-141 / Bremelanotide
Desire • Arousal Support • Injection + Nasal Spray
PT-141, also known as bremelanotide, is a peptide commonly reviewed in sexual-wellness medicine for desire and arousal pathways. IPS may review it in two delivery formats: injection and nasal spray.
Injection is generally the stronger, broader systemic option and is often chosen when patients want the most robust effect. Nasal spray is the needle-free option and is often chosen for convenience, simplicity, and ease of use.
Within IPS, format choice is individualized. Goals, preference, prior response, tolerance, cardiovascular screening, medication review, and overall clinical fit help determine whether either option makes sense.
Injection systemic optionNasal needle-free optionDesire support contextCV risk review
What it supports
What PT-141 supports — and how the formats differ.
Arousal pathways
Commonly reviewed for its role in central nervous system pathways related to sexual arousal.
Injection option
Typically the stronger, broader systemic format and often the better fit when patients want the most robust effect.
Nasal-spray option
The needle-free format and often the better fit when convenience, ease of use, and avoiding injections matter most.
Candidacy
Who may be a fit?
Desire & Arousal Goals
Patients seeking sexual-wellness support, including reduced desire or arousal concerns, can be reviewed after review.
Medically Reviewed Option
Fits patients who want a medically reviewed, non-stimulant sexual-wellness option with individualized candidacy screening.
Broader Health Context
Best considered after hormones, stress, sleep, medication factors, cardiovascular risk, and overall health have been reviewed.
Who may not be a fit
Medical review is especially important.
PT-141 may not be appropriate for everyone. IPS reviews blood pressure, cardiovascular history, rhythm concerns, pregnancy or breastfeeding status, medication interactions, sensitivity concerns, nausea history, and uncontrolled medical or psychiatric conditions before considering this option.
Cardiovascular riskUncontrolled high blood pressure, known cardiovascular disease, elevated cardiovascular risk, or significant heart-rhythm concerns require careful review.
Tolerance reviewPotential side effects can include nausea, flushing, headache, injection-site reactions, vomiting, and temporary blood-pressure or heart-rate changes.
Medication contextMedication interactions, sensitivity concerns, and current therapies should be reviewed before any plan is considered.
No casual-use positioningIPS does not present PT-141 as a casual-use product or a promised sexual-performance solution.
IPS clinical positioning
Sexual Health / Hormonal Optimization
PT-141 is used as a medically reviewed sexual-wellness option that can be reviewed only when appropriate based on health history, risk factors, goals, and response.
Program placement
PT-141 can be reviewed for properly screened patients looking for support with desire, arousal, and sexual confidence as part of a broader clinical review.
Questions
Frequently asked.
What is the difference between injection and nasal spray?
Injection is usually the stronger, broader systemic option. Nasal spray is the needle-free option and is often preferred for simplicity and convenience. IPS reviews goals, tolerance, response, and overall fit before recommending one format over the other.
Is PT-141 the same as bremelanotide?
Yes. PT-141 is commonly known as bremelanotide.
Is PT-141 FDA approved?
Bremelanotide is FDA approved under the brand name Vyleesi for acquired, generalized hypoactive sexual desire disorder in certain premenopausal women. Other uses can be reviewed off-label and require medical review.
Is this for men too?
PT-141 should not be presented as FDA approved for men. It may be reviewed only as an off-label sexual-wellness consideration when medically appropriate.
Is this like Viagra or Cialis?
No. Viagra and Cialis primarily affect blood-flow pathways. PT-141 is commonly reviewed around central nervous system desire and arousal pathways.
Can anyone use it?
No. PT-141 requires consultation and medical review. Cardiovascular history, blood pressure, medication use, and overall health must be reviewed.
Does it have side effects?
Potential side effects can include nausea, flushing, headache, injection-site reactions, vomiting, and temporary blood-pressure or heart-rate changes. Patients should be medically reviewed before use.
Why IPS is different
Not gray market. Not research-only. Not direct-to-consumer peptide kits.
Many consumers encounter products online labeled for research use only, not for human consumption, or laboratory chemicals. Those labels matter because they are not intended for patient care.
RESEARCH USE ONLYNOT FOR HUMAN CONSUMPTIONLABORATORY CHEMICALS
Products marketed online
- May be labeled research use only
- May be labeled not for human consumption
- May be marketed as laboratory chemicals
- May not include patient-specific documentation
- May not involve provider review
The IPS approach
- Consultation before recommendation
- Provider review
- Personalized recommendations
- Medical oversight
- Ongoing guidance and support
Important distinction
A product mixed at home from an online powder and labeled research use only is fundamentally different from care that begins with consultation, provider review, appropriate prescribing, and ongoing clinical guidance.
Membership & Pricing
Transparent access. Medically reviewed. Pharmacy-based fulfillment.
IPS offers two ways to move forward: structured consultation-based programs or membership access for patients who want ongoing guidance and preferred medication pricing.
With membership, patients receive access to member pricing on eligible therapies after consultation, medical review, and approval. Final pricing depends on the selected protocol, pharmacy cost, supply length, clinical requirements, shipping, and provider review.
IPS does not use a public self-selection model. Recommendations are individualized based on goals, health history, candidacy, contraindications, and response.
Consultation-Based Programs
Best for patients who want a specific IPS system recommendation with clear next steps after review.
IPS Membership
Best for patients who want ongoing access, guidance, and preferred member pricing on eligible therapies.
Member Pricing Access
Eligible members may access preferred/wholesale-style medication pricing after medical review. Exact pricing is confirmed before any order is placed.
Not sure which option fits?
Request a ConsultationConsultation
Interested in sexual-wellness support?
Review your desire, arousal, sexual wellness, cardiovascular-risk, medication, and hormone-related goals with IPS.
Medical noteThis page is informational and is not intended to diagnose, treat, cure, or prevent disease. Decisions require qualified clinical care.